American Statistical Association
Rapid advances in sequencing technologies set the stage for large-scale medical sequencing efforts to assess the importance of rare variants in complex diseases. The low frequency and expected large number of such variants pose difficulties for the analysis of these data. We discuss several statistical strategies for association testing with rare variants, and show applications to a study on autism. Implications to study designs will also be discussed.
|Date:||Wednesday, January 26, 2011|
|Time:||4:00 - 5:00 P.M.|
Memorial Sloan-Kettering Cancer Center
Department of Epidemiology and Biostatistics
307 East 63rd Street
(between First and Second Avenues)
New York, New York
Note: To gain access to the building, please follow the directions by the telephone in the foyer.